Efficacy and Safety of Salonsip Compared to Sabiá Plaster (SAL-SIP-03/09)
Clinical Multicenter Study, Randomized, Open, to Evaluate the Efficacy and Safety of Salonsip Compared to Sabiá Plaster Relief of the Signs and Symptoms in Patients With Contusions, Sprains, Injuries and Muscular Injuries With Less Than 24 Hours Early or Holders of Myalgia, Pain and Tendonitis in Regions Miofasciais Articulated.
Sponsor: Hisamitsu Farmaceutica do Brasil Ltda
Listed as NCT00970658, this PHASE3 trial focuses on Contusions and Myalgia and remains ongoing. Sponsored by Hisamitsu Farmaceutica do Brasil Ltda, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hisamitsu Farmaceutica do Brasil Ltda
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.